Apotheek Forum SPRL

Apotheek Forum reported total assets of 465,640 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Jul 2026).

Company number (CBE) 0878.508.907 · VAT BE0878508907
3700 Tongeren-Borgloon
active in Retail sale of pharmaceutical products (NACE 47730)
operating since 12 Dec 2005 (≈ 21 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Apotheek Forum shows with a free account.

See the score
Profile
SPRL since 2005
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result−3,710 €
Equity23,550 €
Cash447 €
EBITDA3,568 €
Total assets465,640 €
The line marks its sector median: 44.2% (2068 companies).

Change 2022 → 2025: Equity +28 % Total assets +18 %

Accounts of the company itself (not consolidated).

The full file covers 8 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Apotheek Forum's annual accounts

20252024202320222021
Net result−3,710 €
Equity23,550 €
Cash447 €
EBITDA3,568 €
Total assets465,640 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 27 Jul 2026
  • Year ended 31 Dec 2024filed on 30 Aug 2025
  • Year ended 31 Dec 2023filed on 29 Aug 2024
  • Year ended 31 Dec 2022filed on 25 Jul 2023
  • Year ended 31 Dec 2021filed on 30 Sep 2022

Apotheek Forum's financial analysis

Management and control of Apotheek Forum

1 active director(s) in the register.

Apotheek Forum's shareholders and holdings →

Apotheek Forum's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0878.508.907
VAT number
BE0878508907
Peppol
Registered · 0208:0878508907 · as of 10 Nov 2026
Legal form
SPRL
Incorporated
12 Dec 2005
Registered office
3700 Tongeren-Borgloon
Latest accounts
2025 · filed on 27 Jul 2026
Activity
Retail sale of pharmaceutical products (NACE 47730)

Apotheek Forum (SPRL) has been based in Tongeren-Borgloon since 2005, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 3,710 € and equity of 23,550 €; its revenue is not published. Its solvency stands at 5.1%, below the median of its sector (44.2%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Apotheek Forum

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Apotheek Forum

What is the revenue of Apotheek Forum?

Apotheek Forum files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Apotheek Forum?

In Belgium, the VAT number is the company number prefixed with BE: BE0878508907 for Apotheek Forum, if the company is VAT-registered. Its company number (CBE) is 0878.508.907.

Where is the registered office of Apotheek Forum?

According to the CBE register, the registered office of Apotheek Forum is in 3700 Tongeren-Borgloon.

What is the equity of Apotheek Forum?

At the close of the 2025 financial year, the equity of Apotheek Forum amounts to 23,550 €, a solvency of 5.1% of total assets.

Who manages Apotheek Forum?

The register lists 1 active mandates at Apotheek Forum. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Apotheek Forum

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 29 Jul 2026

No credit card, no commitment.

What each plan unlocks →